Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 2, 2007, Pages 432-440

  Suzuki, Jun ichi ^a   Ogawa, Masahito ^a   Maejima, Yasuhiro ^a   Isobe, Kazuya ^a   Tanaka, Hiroyuki ^a   Sagesaka, Yuko M ^b   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b 421 0516   (Japan)

Author keywords

Cytokine; Inflammation; Myocardial ischemia; Polyphenols

Indexed keywords

CATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CATECHIN; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; TEA; VENTRICULAR REMODELING;

RATTUS;

EID: 33846365020     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.10.006     Document Type: Article

References (49)

1. Mukamal K.J., Maclure M., Muller J.E., Sherwood J.B., and Mittleman M.A. Tea consumption and mortality after acute myocardial infarction. Circulation 105 (2002) 2476-2481
2. Arts I.C.W., Peter Hollman P.C.H., Feskens E.J.M., de Mesquita H.B.B., and Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am. J. Clin. Nutr. 74 (2001) 227-232
3. Morishita R., Sugimoto T., Aoki M., Kida I., Tomita N., Moriguchi A., Maeda K., et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat. Med. 3 (1999) 894-899
4. Li C., Browder W., and Kao R.L. Early activation of transcription factor NF-kB during ischemia in perfused rat heart. Am. J. Physiol. 45 (1999) H543-H552
5. Li Q., and Verma I.M. NF-kB regulation in the immune system. Nat. Rev., Immunol. 2 (2002) 725-734
6. Chandrasekar B., and Freeman G.L. Induction of nuclear factor B and activation protein 1 in postischemic myocardium. FEBS Lett. 401 (1997) 30-34
7. Onai Y., Suzuki J., Kakuta T., Maejima Y., Haraguchi G., Fukasawa H., Muto S., et al. Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc. Res. 63 (2004) 51-59
8. Ishikawa T., Suzukawa M., Ito T., Yoshida H., Ayaori M., Nishiwaki M., et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 66 (1997) 261-266
9. Junkun J., Selman S.H., Swiercz R., and Skrzypczak-Jankun E. Why drinking tea could prevent cancer. Nature 387 (1997) 561
10. Beecher G.R., Warden B.A., and Merken H. Analysis of tea polyphenols. Proc. Soc. Exp. Biol. Med. 220 (1999) 267-270
11. Yang C.S., Landau J.M., Huang M.T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21 (2001) 381-406
12. Lin Y.L., and Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 52 (1997) 465-472
13. Benelli R., Vene R., Bisacchi D., Garbisa S., and Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol. Chem. 383 (2002) 101-105
14. Suzuki J., Ogawa M., Izawa A., Sagesaka Y.M., and Isobe M. Dietary consumption of green tea catechins attenuate hyperlipidemia-induced atherosclerosis and systemic organ damage in mice. Acta Cardiol. 60 (2005) 271-276
15. Suzuki J., Ogawa M., Futamatsu H., Kosuge H., Sagesaka Y.M., and Isobe M. Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation, fibrosis, and alter cytokine expression in rat autoimmune myocarditis. Eur. J. Heart Fail. (2006, Jul 7) [electronic publication ahead of print]
16. Suzuki J., Ogawa M., Sagesaka Y.M., and Isobe M. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovasc. Res. 69 (2005) 272-279
17. Townsend P.A., Scarabelli T.M., Pasini E., Gitti G., Menegazzi M., Suzuki H., et al. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 18 (2004) 1621-1623
18. Aneja R., Hake P.W., Burroughs T.J., Denenberg A.G., Wong H.R., and Zingarelli B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol. Med. 10 (2004) 55-62
19. Sandmann S., Spitznagel H., Chung O., Xia Q.G., Illner S., Janichen G., et al. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc. Res. 39 (1998) 339-350
20. Futamatsu H., Suzuki J., Kosuge H., Yokoseki O., Kamada M., Ito H., et al. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc. Res. 59 (2003) 95-104
21. Futamatsu H., Suzuki J., Mizuno S., Koga N., Adachi S., Kosuge H., et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 96 (2005) 823-830
22. Renard P., Ernest I., Houbion A., Art M., Calvez H.L., Martine Raes M., et al. Development of a sensitive multi-well colorimetric assay for active NFκB. Nucleic Acids Res. 29 (2001) e21
23. Keliner D.E., and Stetler-Stevenson W.G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218 (1994) 325-329
24. Maejima Y., Adachi S., Morikawa K., Ito H., and Isobe M. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J. Mol. Cell. Cardiol. 38 (2005) 163-174
25. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 130 8S Suppl. (2000) 2073S-2085S
26. Weisburger J.H. Lifestyle, health and disease prevention: the underlying mechanisms. Eur. J. Cancer Prev. 11 Suppl. 2 (2002) S1-S7
27. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp. Clin. Res. 28 (2002) 49-62
28. Lambert J.D., and Yang C.S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res.. 523-524 (2003) 201-208
29. Kudo M., Naito Z., Yokoyama M., and Asano G. Effects of quercetin and sunphenon on responses of cancer cells to heat shock damage. Exp. Mol. Pathol. 66 (1999) 66-75
30. Takabayashi F., and Harada N. Effects of green tea catechins (Polyphenon 100) on cerulein-induced acute pancreatitis in rats. Pancreas 14 (1997) 276-279
31. Locher R., Emmanuele L., Suter P.M., Vetter W., and Barton M. Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur. J. Pharmacol. 434 (2002) 1-7
32. Lin J.K., Liang Y.C., and Lin-Shiau S.Y. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58 (1999) 911-915
33. Unno T., and Takeo T. Absorption of (-)-epigallocatechin gallate into the circulation system of rats. Biosci. Biotechnol. Biochem. 59 (1995) 1558-1559
34. Chen L., Lee M.J., Li H., and Yang C.S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos. 25 (1997) 1045-1050
35. Okushio K., Suzuki M., Matsumoto N., Nanjo F., and Hara Y. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos. 27 (1999) 309-316
36. Nakagawa K., and Miyazawa T. Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma. Anal. Biochem. 248 (1997) 41-49
37. Nakagawa K., Okuda S., and Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem. 61 (1997) 1981-1985
38. Yang F., Oz H.S., Barve S., de Villiers W.J., McClain C.J., and Varilek G.W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60 (2001) 528-533
39. Pan M.H., Lin-Shiau S.Y., Ho C.T., Lin J.H., and Lin J.K. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem. Pharmacol. 59 (2000) 357-367
40. Park A.M., and Dong Z. Signal transduction pathways: targets for green and black tea polyphenols. J. Biochem. Mol. Biol. 36 (2003) 66-77
41. Samara W.M., and Gurbel P.A. The role of platelet receptors and adhesion molecules in coronary artery disease. Coron. Artery Dis. 14 (2003) 65-79
42. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94 (2004) 1543-1553
43. Hayashidani S., Tsutsui H., Shiomi T., Ikeuchi M., Matsusaka H., Suematsu N., et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108 (2003) 2134-2140
44. Yamazaki T., Seko Y., Tamatani T., Miyasaka M., Yagita H., Okumura K., et al. Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am. J. Pathol. 143 (1993) 410-418
45. Lindsey M.L. MMP induction and inhibition in myocardial infarction. Heart Fail. Rev. 9 (2004) 7-19
46. Vanhoutte D., Schellings M., Pinto Y., and Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc. Res. 69 (2006) 604-613
47. Hudson M.P., Armstrong P.W., Ruzyllo W., Brum J., Cusmano L., Krzeski P., et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J. Am. Coll. Cardiol. 48 (2006) 15-20
48. El Bedoui J., Oak M.H., Anglard P., and Schini-Kerth V.B. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc. Res. 67 (2005) 317-325
49. Cheng X.W., Kuzuya M., Nakamura K., Liu Z., Di Q., Hasegawa J., et al. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1864-1870